This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Howard S. Lazarus, MD; Gregory S. Hageman, PhD

Arch Ophthalmol. 1994;112(10):1356-1362.

Abstract
Objective
To provide more definitive evidence regarding the cellular origin of hyalocytes and to establish a basis for their identification in tissue specimens.

Methods
Hyalocytes were examined in situ in human eyes from 10 donors (aged 1 to 63 years) with use of a panel of antibodies and lectins directed against determinants associated with leukocytic and nonleukocytic cells.

Results
Hyalocytes express the leukocyte-associated antigens CD45, CD11a, and CD64, an antigen expressed constitutively only by monocytes and macrophages. However, they do not react with antibodies against CD68, an antigen that is expressed by virtually all tissue macrophages, or CD 1 lb and CD 14, antigens that are variably expressed by the monocyte/macrophage lineage. They also react with antibodies against major histocompatibility complex class II antigens and S100, both of which are expressed by a variety of cell types. The lectins Dolichos biflorus, Sambucus nigra, Griffonia simplicifolia, Limax flavus, and Ricinus communis I bind hyalocyte-associated glycoconjugates; no binding was observed with Arachis hypogaea or Glycine max.

Conclusions
These results provide strong evidence that hyalocytes belong to the monocyte/macrophage lineage but differ significantly from other tissue macrophages in that they express S100 protein and do not express CD68. This information should provide a basis for the identification of hyalocytes in tissue specimens and an improved understanding of vitreoretinal pathologic features.

Author Affiliations
From The Wilmer Ophthalmological Institute, The Johns Hopkins Hospital, Baltimore, Md (Dr Lazarus), and the Anheuser-Busch Eye Institute, Department of Ophthalmology, St Louis (Mo) University School of Medicine (Dr Hageman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sialoadhesin Expression in Intact Degenerating Retinas and Following Transplantation
Sancho-Pelluz et al.
IOVS 2008;49:5602-5610.
ABSTRACT | FULL TEXT  

Role of TGF-{beta} in proliferative vitreoretinal diseases and ROCK as a therapeutic target
Kita et al.
Proc. Natl. Acad. Sci. USA 2008;105:17504-17509.
ABSTRACT | FULL TEXT  

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
Kawahara et al.
Diabetes 2008;57:2784-2793.
ABSTRACT | FULL TEXT  

Retinal Microglia and Uveal Tract Dendritic Cells and Macrophages Are Not CX3CR1 Dependent in Their Recruitment and Distribution in the Young Mouse Eye
Kezic et al.
IOVS 2008;49:1599-1608.
ABSTRACT | FULL TEXT  

Transforming Growth Factor-{beta}2 and Connective Tissue Growth Factor in Proliferative Vitreoretinal Diseases: Possible Involvement of Hyalocytes and Therapeutic Potential of Rho Kinase Inhibitor
Kita et al.
Diabetes 2007;56:231-238.
ABSTRACT | FULL TEXT  

The characterisation of hyalocytes: the origin, phenotype, and turnover
Qiao et al.
Br J Ophthalmol 2005;89:513-517.
ABSTRACT | FULL TEXT  

The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes
Hirayama et al.
IOVS 2004;45:3896-3903.
ABSTRACT | FULL TEXT  

Functional Properties of Hyalocytes under PDGF-Rich Conditions
Noda et al.
IOVS 2004;45:2107-2114.
ABSTRACT | FULL TEXT  

Hyalocytes Synthesize and Secrete Inhibitors of Retinal Pigment Epithelial Cell Proliferation In Vitro
Lazarus et al.
Arch Ophthalmol 1996;114:731-736.
ABSTRACT